The argument(s) for lowering the US minimum required content of apheresis platelet components
Transfusion
.
2019 Apr;59(4):1404.
doi: 10.1111/trf.15233.
Authors
Richard J Benjamin
1
,
Lou Katz
2
,
Richard Gammon
3
,
Eva Quinley
4
;
Consortium for Blood Availability
1
Affiliations
1
Cerus Corporation, Concord, CA.
2
Americas Blood Centers, Washington, DC.
3
OneBlood, Inc, Orlando, FL.
4
Vitalant, Pittsburgh, PA.
PMID:
30950091
DOI:
10.1111/trf.15233
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Component Removal*
Blood Platelets*